Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of November 8 Dividend Increases/Decreases for the Week of November 1 Dividend Increases/Decreases for the Week of October 25 Dividend Increases/Decreases for the Week of October 18 Dividend Increases/Decreases for the Week of October 11 Dividend Increases/Decreases for the Week of October 4

Results 181 - 190 of 219 for cl. (2.16 seconds) Intel Beats Consensus Estimates and Weak PC Demand Newsletter portfolio holding Intel reported solid results... Keeping Both eBay and PayPal after Split Best Ideas Newsletter portfolio holding eBay reported... Roche’s Hemlibra Looks Very Promising Image shown: Roche's shares caught some relief... The Damage Has Already Been Done Nearly $5 trillion in wealth has been wiped... As the World Turns We’re keeping our eyes on a number of things.... Canakinumab Posts Some Impressive Data For Novartis Image Source: Novartis. We remain impressed with the... Upadacitinib Posts Impressive Data for AbbVie Image Source: AbbVie. In the pharmaceutical realm,... Best in Biotech? Global Blood Therapeutics' Promising Treatment for Sickle Cell Anemia Image Source: National Institute for Health. We... GE Cuts Guidance, All Eyes Turn to November 13 Image Source: darkon_turaas. On October 20, General... Restasis Patent Protection Weighing on Shares of Allergan Image Source: Allergan. We have witnessed numerous... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | next